Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database | Zendy

David B. Nelson | Zendy; David C. Rice | Zendy; K. G. Mitchell | Zendy; Anne S. Tsao | Zendy; Ara A. Vaporciyan | Zendy; Mara B. Antonoff | Zendy; Wayne L. Hofstetter | Zendy; Garrett L. Walsh | Zendy; Stephen G. Swisher | Zendy; Jack A. Roth | Zendy; Daniel R. Gomez | Zendy; Reza J. Mehran | Zendy; Boris Sepesi | Zendy

Open Access

Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database

Author(s) -

David B. Nelson,

David C. Rice,

K. G. Mitchell,

Anne S. Tsao,

Ara A. Vaporciyan,

Mara B. Antonoff,

Wayne L. Hofstetter,

Garrett L. Walsh,

Stephen G. Swisher,

Jack A. Roth,

Daniel R. Gomez,

Reza J. Mehran,

Boris Sepesi

Publication year - 2019

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2019.04.27

Subject(s) - medicine , propensity score matching , hazard ratio , radiation therapy , oncology , adjuvant , stage (stratigraphy) , proportional hazards model , adjuvant radiotherapy , cancer , mesothelioma , surgery , pathology , confidence interval , paleontology , biology

Adjuvant radiation was associated with improved survival among those with pathologic stage I-II MPM. No survival advantage was observed for those with pathologic stage III or stage IV MPM, however. Our results justify the need for further prospective trials to investigate the utility of adjuvant radiotherapy among those with MPM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research